Atlanta, GA – January 2022 – JScreen, a national non-profit public health initiative dedicated to preventing genetic diseases, announced plans to participate in the third annual Jewish Genetic Screening Awareness Week (JGSAW) February 1 – 7, 2022. Initiated two years ago with organizational partners across the nation, JGSAW serves to educate the Jewish community about the importance of screening for genetic diseases and raise awareness about testing resources through a week of powerful events and timely information. Jewish Genetic Screening Awareness Week will be officially recognized in the morning orders by the Georgia State Legislature according to the Proclamation Declaring Jewish Genetic Screening Awareness Week passed two years ago.

JScreen makes genetic testing simple, accessible, and affordable by offering easy-to-use at-home saliva kits. JScreen’s reproductive test gives prospective parents a deep understanding of their genetic makeup and the risk of having a child with a genetic disease.  If a couple’s risk is elevated, genetic counselors privately address their results by phone or video teleconference and provide them with options to help them plan for the health of their future children. JScreen’s cancer genetic test alerts a person to their risk for hereditary cancer. If results are positive, it allows them to take action for the prevention or early detection of many common cancers. By providing convenient at-home access to cutting-edge genetic testing technology, patient education, and genetic counseling services, JScreen strives to prevent devastating genetic diseases and ensure a bright and healthy future for all.

“Our #1 goal is to ensure a healthy future by preventing genetic diseases through screening and education,” says Karen Arnovitz Grinzaid, Executive Director of JScreen. “For the third consecutive year, we’re proud to promote Jewish Genetic Screening Awareness Week. We’re asking for your help in making that healthy future a reality by raising awareness and showing your support for the life-saving power of genetic testing. This week will showcase valuable resources and events to get more people tested and save more lives.”’

“It is my absolute pleasure to work alongside JScreen to raise awareness about the vital importance of genetic screening,” said Mike Wilensky, State Rep. of Georgia HD79 who introduced the resolution declaring Jewish Genetic Screening Awareness Week. “In our third year promoting Jewish Genetic Screening Awareness Week, we endeavor to make sure the message is understood loud and clear: take action, take control, and get screened.”

During JGSAW, JScreen is offering a $113 off coupon code for testing for people living in Colorado. Register for testing at www.jscreen.org and use code ColoradoScreens at checkout to receive the discount.

For more information, please visit www.jscreen.org.

About JScreen

JScreen is a national non-profit public health initiative dedicated to preventing Jewish genetic diseases. Headquartered in Atlanta at Emory University School of Medicine, the JScreen initiative provides convenient at-home access to cutting-edge genetic testing technology, patient education and genetic counseling services. JScreen believes the combination of education, access to premier gene screening technologies and personalized, confidential support are the keys to preventing these devastating diseases.